Please login to the form below

Not currently logged in
Email:
Password:

disease management

This page shows the latest disease management news and features for those working in and with pharma, biotech and healthcare.

Homesick

Homesick

The cataclysmic manifestation of the problem may lie in the effects that we see with respect to chronic disease management. ... This tsunami of chronic disease management patients who are missing regular and routine  care, the reticence to rebook

Latest news

  • Key emerging trends in digital health Key emerging trends in digital health

    With the potential to ease the demand on overstretched healthcare systems across the world, while simultaneously offering patients the opportunity to control their own disease management, digital health offers an opportunity ... Other chronic conditions,

  • QiC Dermatology is now open for entry QiC Dermatology is now open for entry

    The journal publishes a broad array of articles covering all aspects of skin disease, including – but not limited to – therapeutic developments, clinical articles; from diagnosis to management, practical guides and case ... involved in the diagnosis,

  • Pharma’s race to digital Pharma’s race to digital

    The mobile health market is expanding rapidly and digital therapeutics (DTX) could one day rival mainstream pharmaceuticals in areas such as chronic disease management. ... Already there are examples of digital solutions that allow earlier diagnosis,

  • The end of pharma The end of pharma

    They will develop, provide and maintain disease management systems that incorporate pharmaceuticals but also diagnostic and delivery devices and, probably, patient-flow management systems.

  • The business case for patient engagement The business case for patient engagement

    Over three days in spring 2019, we ran a short, ten-question questionnaire (Patients’ attitudes towards NOACs) for nearly 850 anticoagulation patients using MyTherapy, our medication and disease management app.

More from news
Approximately 4 fully matching, plus 175 partially matching documents found.

Latest Intelligence

  • How COVID-19 is accelerating the threat of antimicrobial resistance How COVID-19 is accelerating the threat of antimicrobial resistance

    AMR threatens our ability to treat common infections and increases the risk of medical procedures such as transplants, chemotherapy, chronic disease management and major surgery.

  • Encouraging patient participation in real-world studies Encouraging patient participation in real-world studies

    It must go beyond understanding side effects and modes of action to include their ‘lived experience’ with the disease. ... ICON:With patients and their families increasingly looking beyond their healthcare professional for disease information,

  • Mapping the patient journey and minding the gap Mapping the patient journey and minding the gap

    3. Look beyond the disease. The best patient engagement focuses on the person not the disease. ... opportunity, to caring for consumers right through the disease life cycle; prevention, diagnosis, management and maintenance.

  • Growing up as a patient is hard to manage Growing up as a patient is hard to manage

    There can also also be varying adherence levels within a single disease management regimen. ... As well as the short-term effects on disease management and outcomes, poor adherence during adolescence can also have detrimental, long-term effects.

  • Creating value from value-based healthcare Creating value from value-based healthcare

    the Ministry of Health to provide insight into outcomes for 50% of the disease burden by 2022. ... Towards co-creation. Industry can build on its role as a partner in disease management and become a key stakeholder in the governmental, legislative and

More from intelligence
Approximately 0 fully matching, plus 54 partially matching documents found.

Latest appointments

  • BMS appoints new commercial leader, Davies joins Eisai and more BMS appoints new commercial leader, Davies joins Eisai and more

    The field of genomic medicine has the potential to revolutionise our approach to rare genetic disease diagnosis and management, as well as in other areas of personalised medicine.”. ... Atkins said: “Britten joins our Senior Management team at a

  • Hugh Cole joins Jounce Therapeutics as chief business officer Hugh Cole joins Jounce Therapeutics as chief business officer

    Cole brings over 25 years’ experience in biotech including business development, corporate strategy, R&D, alliance management, commercial planning and execution and corporate leadership. ... He has also held roles for Oscient Pharmaceuticals, The

  • Glyconics appoints CEO Glyconics appoints CEO

    Dr Kam Pooni joins the UK diagnostics firm. UK disease management diagnostics firm Glyconics has appointed Dr Kam Pooni as chief executive officer with immediate effect.

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 32 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Onyx Health Ltd

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics